Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
FDA Greenlights Phase 1 Trial for IOPCL Magnifier
OnPoint Vision has officially received FDA approval for their investigational device exemption (IDE) application, initiating the phase 1 in the pivotal clinical trial for the AccuraSee Intraocular Pseudophakic Capsular Lens (IOPCL) Magnifier (MAG). This trial focuses on the secondary implantation…
What Is Idiopathic Multifocal Choroiditis and How to Manage It|OBN
What Is Idiopathic Multifocal Choroiditis? Idiopathic Multifocal Choroiditis (IMFC) is a rare eye condition that primarily affects the choroid, a vascular layer situated between the retina and the sclera (the white part of the eye). The condition is characterized by…
Large-Scale Study Sheds Light on Rare Eye Disorders
Researchers have analyzed image and genomic data from the UK Biobank to find insights into rare diseases of the human eye. These include retinal dystrophies – a group of inherited disorders affecting the retina – which are also the leading…
What Is Leber Congenital Amaurosis?
Leber Congenital Amaurosis (LCA) is a rare genetic disorder that affects the retina, the part of the eye responsible for sensing light and sending visual signals to the brain. It is a severe form of retinal dystrophy, which means that…
Dysphotopsia: Causes, Symptoms, Treatment | OBN
What Is Dysphotopsia? Dysphotopsia, a term often sending shivers down the spine of even the most experienced ophthalmologists, refers to a spectrum of visual disturbances that patients may experience following cataract surgery. It is derived from the Greek words ‘dys’…
Japan’s PMDA Approves Aurion Biotech’s NDA
Aurion Biotech announced that it has received regulatory approval from Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for its pioneering cell therapy, VyznovaTM, designed for treating bullous keratopathy of the cornea. According to the company, this represents the world’s first…
VSY’s SVT Technology Secures Patent Grant in the US
Andreas C. Kühnel, Managing Director at VSY Biotechnology announced that the company’s innovative Sinusoidal Vision Technology (SVT®) has received its U.S. patent from the United States Patent and Trademark Office. This significant milestone is a testament to the company’s commitment…
Tiny Eye Implant: A Diabetes Treatment Option
In Sweden, researchers have created a microscale device designed for implantation in the eye, opening up new paths for cell-based treatments for conditions like diabetes. Developed by a team from KTH Royal Institute of Technology and Karolinska Institutet, this 3D-printed…
XPANCEO Raises $40M for AR Vision Contact Lenses
XPANCEO, a deep tech startup, has secured $40 million in seed funding to introduce groundbreaking contact lenses with augmented reality (AR) vision features. These funds will be strategically channeled into the development of the next prototype, consolidating multiple features within…
ICTER’s New Imaging Method for Early Diagnosis
Optical coherence tomography (OCT) stands as one of the most foundational and accurate tests for diagnosing eye diseases. While it excels in a detailed examination of individual eye structures, its effectiveness diminishes when applied to the early detection of subtle…